Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Oct 2026 for Alaunos Therapeutics, Inc., €14k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Michael Allen Jerman: trading record in brief
This profile gathers the share dealings of Michael Allen Jerman across 2 companies, led by Alaunos Therapeutics, Inc. and Inhibitor Therapeutics, Inc. We count 8 filings; the first trade dates from 1 April 2024 and the latest from 6 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 8 October 2026: a share grant of €14k, in Alaunos Therapeutics, Inc. Typically, a trade is published a median of 5 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Allen Jerman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
20,990 shares@ US$0.7444Common StockSEC:0001193125-26-417974:0
8,138 shares@ US$1.920.56% mcap26.3% of flowCommon StockSEC:0001193125-26-318114:0
50,000 shares0Common StockSEC:0001493152-26-029898:0
6,032 shares@ US$2.590.30% mcap25.7% of flowCommon StockSEC:0001193125-26-201474:0
5,406 shares@ US$2.8925.9% of flowCommon StockSEC:0001193125-26-014117:0
4,183 shares@ US$3.1622.1% of flowCommon StockSEC:0001193125-25-301025:0
50,000 shares0Common StockSEC:0001641172-25-003023:0
50,000 shares0Common StockSEC:0001493152-24-020170:0
8 of 8 declarations
